This inventor holds 1 USPTO granted patent. Top assignee: Shin Poong Pharmaceutical Co., Ltd.. Active years: 2000.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2000
Title: Seung Kyun Roh: Innovator in Injectable Composition Technology
Introduction: Seung Kyun Roh is a notable inventor based in Ansan, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of stable injectable compositions. His work focuses on enhancing the stability and efficacy of medical formulations.
Latest Patents: Roh holds a patent for a "Stable prostaglandin E1-containing injectable composition." This invention relates to a stable injectable composition that contains prostaglandin E1. The composition is prepared by dissolving prostaglandin E1 in a sodium citrate/citric acid buffer solution, filtering the resulting solution under aseptic conditions, and then lyophilizing the filtrate. This innovative approach ensures that prostaglandin E1 is stably maintained even during long-term storage. Roh's patent is a testament to his commitment to improving pharmaceutical formulations, with 1 patent to his name.
Career Highlights: Seung Kyun Roh has established himself as a key figure in the pharmaceutical industry. He is currently associated with Shin Poong Pharmaceutical Co., Ltd., where he continues to work on innovative solutions in drug formulation. His expertise and dedication have made him a valuable asset to his company and the broader medical community.
Collaborations: Throughout his career, Roh has collaborated with talented professionals in the field. Notable coworkers include Sung Tae Lee and Eung Bae Kim, who have contributed to various projects alongside him. Their collective efforts have further advanced the research and development of pharmaceutical products.
Conclusion: Seung Kyun Roh's contributions to the field of injectable compositions highlight his innovative spirit and dedication to improving medical treatments. His work not only enhances the stability of important drugs but also reflects the ongoing advancements in pharmaceutical technology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile